SEC Form 4/A · accession 0001209191-15-066382
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Christopher Kemmerer
Officer — VP, Pharma Dev & Manufacturing
Period of report
Aug 7, 2015
Accepted (ET)
Aug 17, 2015 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 7, 2015 | M | 1,000 | $1.342 | A | 11,848 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4,F1,F2,F3 | $1.342 | Aug 7, 2015 | M | 1,000 | D | — | Feb 6, 2024 | Common Stock | 1,000 | 51,182 | D |
Explanation of responses
- F1The original Form 4 Report filed on August 10, 2015 incorrectly stated the price as $1.22.
- F2Option shares vest in 48 equal installments measured from the vesting commencement date, 02/06/2014.
- F3The original Form 4 Report filed on August 10, 2015 incorrectly stated the expiration date as 01/07/2019.
- F4The original Form 4 Report filed on August 10, 2015 incorrectly stated the number of derivative securities as 1,710.